Client List
        

Below is a list of some of the past as well as current clients of B&H Consulting Services, Inc. Also included is a sample of client testimonials. By contractual agreement, not all companies are listed.
 

Actelion Clinical Research, Inc.
Action Pharma A/S
Astion Pharma A/S
Boston Life Sciences, Inc.
Bristol-Myers Squibb 
Bristol-Myers Products
Colgate-Palmolive Company
CURA Pharmaceutical Company, Inc.
EBEWE Pharma Ges.m.b.H. Nfg.KG
Egalet A/S
Enzon Pharmaceuticals, Inc.
Fugisawa USA, Inc.
Genmab A/S
hameln rds gmbh
INO Therapeutics
Johnson & Johnson Consumer & Personal Products Worldwide
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Maganin Pharmaceuticals, Inc.
Novartis Consumer Health, Inc.
Novo Nordisk Pharmaceuticals, Inc.
Praecis Pharmaceuticals, Inc.
Roche Pharmaceuticals, Inc.
Schering Plough Animal Health
Synthelabo Recherche
Takeda America, Inc.
Zenith Goldline Pharmaceuticals
Zealand Pharmaceutical A/S
Zymenex A/S
Return to Top


Testimonials

We are very happy with the services B&H has provided over the past two years.  They have worked collaboratively with EBEWE to successfully submit several ANDAs.  B&H has been an integral part of responding to the chemistry, microbiology and labeling deficiencies from FDA for these ANDAs.  B&H has also successfully prepared and submitted a 505(b)(2) NDA for EBEWE, which recently received FDA approval for the US market.  They have undoubtedly contributed to EBEWE's successful entry into the US market.  I would highly recommend the B&H team!

Dr. Wolfgang Schmitzberger
Chief Operations Officer
EBEWE Pharma Ges.m.b.H. Nfg.KG
October 2007

Return to Top

The co-operation with B&H Consulting was excellent due to their professional and committed work. What impressed me the most was how fast and yet still accurate things were handled. All requests were dealt with promptly and to our satisfaction.
Dr. Christian Liek
Head of Regulatory Affairs
hameln rds gmbh
October 2007

Return to Top

Hallmarks of dossier services by B&H Consulting:  timely, professional, experienced, thorough, and, most important of all, in step with latest developments on regulatory dossier requirements.
HY Guh, Ph.D.
Chairman
Andaxa LLC
 
Return to Top

We at Cura are very pleased with the value B&H provides us for our Regulatory requirements. We have found them to be very thorough and comprehensive in their approach to providing solutions for our issues. They are a very knowledgeable group with a "human" touch.  
Fabio Lanzieri
President
Cura Pharmaceutical Company, Inc.  
 
Return to Top

Genmab is a Scandinavian based (Denmark) company, developing fully human antibodies for therapeutic use. Genmab was founded in year 1999. Genmab had our first IND filing with the FDA in year 2000, with B&H Consulting Services acting as our US agent and liaison to the FDA. Our collaboration has been so successful, that we have decided to slow down activities towards filling regulatory affairs positions in our US affiliate. Still today, B&H is our liaison to the U.S. FDA. Their dedication toward delivering quality work on time, along with clever consultancy, has made them a very important extension to Genmab that we would rather not be without. I can only recommend B&H Consulting Services to any company who needs regulatory services.  
Hanne Damgaard Jensen
Director of Regulatory Affairs, QA & Project Management
Genmab A/S

Return to Top

In my experience over a number of years, B&H Consulting Services, Inc. has demonstrated the ability to service both “big pharma and little pharma” with a variety of regulatory services.  They can complete a discrete job such as preparing a specific document for submission, or can provide an extra staffing resource within your company.  In the latter case, the people they place within your company achieve a level of transparency based on professionalism, competencies, and an innate ability to feel and respond to the pulse of the organization.  B&H can also provide strong regulatory strategic guidance based upon a wealth of regulatory experience and intelligence and expertise in knowing the current regulations.
S. Cottrell, Ph.D.
Regulatory Affairs
Novo Nordisk A/S

Return to Top

During the several years that B&H Consulting Services prepared scientific documents, INDs, NDAs and amendments for projects with which I was associated, one could not have asked for more from a consulting company in the area of CM&C document preparation.   The quality of the work, the responsiveness to changing needs, the adherence to milestones and deadlines were superb and contributed immensely to the successful registration of a number of products in an expeditious manner.  B&H is a unique consulting company to the pharmaceutical industry which provides valuable services to clients.
Irwin S. Gibbs, Ph.D.
Director of Pharmaceutical Development
(Retired)

Return to Top

What impresses me about B&H is that, to them, a deadline is a deadline, not a suggestion. Not only did they meet my deadlines with top-notch work, they were professional, responsive, courteous, and adaptive. It was a pleasure working with them.
Yinka Williams, Ph.D.
Director, Chemical and Pharmaceutical Development Team Leader  

Return to Top

B&H Consulting Services, Inc. was recommended to us by our Danish business contact. We have worked with B&H on a number of projects since early 2002.  They have proven to be an invaluable contact within the US for our projects.  Their staff has a great level of expertise in a number of different areas, including CMC and clinical research.  Their good contacts within the FDA have greatly facilitated the progress of development projects to the IND stage. In our experience with B&H, all project issues are dealt with promptly and with a great attention to detail.
Jürgen Regenold  
Chariman
Dr. Regenold GmbH

Return to Top

 


 

55 North Gaston Avenue   Somerville, NJ 08876 USA     Tel: 908-704-1691   Fax: 908-704-1693    mail@bhconsultingservices.com